Codexis (CDXS) Deferred Taxes (2014 - 2017)

Codexis (CDXS) posted quarterly Deferred Taxes of $52000.0 for Q3 2017, down 80.23% quarter-over-quarter from $263000.0 in Q3 2015.

Codexis (CDXS) Deferred Taxes (2014 - 2017) Analysis & Trends

Codexis' Deferred Taxes history runs 3 years deep, the most recent figure standing at $52000.0 for Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-69.70 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	194.40 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	2.66 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Codexis	143.86 Mn	88.95 Mn	11.40 Mn	-

Download Data